Glasgow Early Treatment Arm Favirpiravir (GETAFIX) for adults with early stage COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引：7

作者：

Hanna, Catherine R. ^{[1
,2
,3
]}

Blyth, Kevin G. ^{[2
,3
]}

Burley, Glenn ^{[4
]}

Carmichael, Samantha ^{[2
]}

Evans, Carol ^{[1
]}

Hinsley, Samantha ^{[1
]}

Khadra, Ibrahim ^{[4
]}

Khoo, Saye ^{[5
]}

Lewsley, Liz-Anne ^{[1
]}

Jones, Robert R. ^{[2
,3
]}

Sharma, Raman ^{[6
]}

Taladriz-Sender, Andrea ^{[4
]}

Thomson, Emma C. ^{[7
]}

Scott, Janet T. ^{[2
,7
]}

机构：

[1] Univ Glasgow, CRUK Clin Trials Unit, Glasgow, Lanark, Scotland

[2] NHS Greater & Glasgow Clyde, Glasgow, Lanark, Scotland

[3] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland

[4] Univ Strathclyde, Glasgow, Lanark, Scotland

[5] Univ Liverpool, Dept Pharmacol, Liverpool, Merseyside, England

[6] Univ Liverpool Liverpool Sch Trop Med, Dept Trop Dis Biol, Liverpool, Merseyside, England

[7] Univ Glasgow, Inst Infect Immun & Inflammat, MRC Univ Glasgow Ctr Virus Res, Glasgow, Lanark, Scotland

来源：

基金：

英国医学研究理事会;

关键词：

COVID-19; Randomised controlled trial; protocol; favipiravir; inpatient; outpatient; early; pharmacokinetics; safety; tolerability; antiviral;

D O I：

10.1186/s13063-020-04891-1

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：3